FGF‐2 isoforms of 18 and 22.5 kDa differentially modulate t‐PA and PAI‐1 expressions on the pancreatic carcinoma cells AR4–2J: Consequences on cell spreading and invasion

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International Journal of Cancer

• Publication date

  2000-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0215(20000215)85:4<555::AID-IJC18>3.0.CO;2-HPMID 10699930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro

  1998cited by this paper
• An active zymogen: unravelling the mystery of tissue-type plasminogen activator.

  1998cited by this paper
• Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.

  1998cited by this paper
• Vascular endothelial growth factor (VEGF)‐C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity

  1998cited by this paper
• Role of Fibroblast Growth Factors and Their Receptors in Pancreatic Cancer and Chronic Pancreatitis

  1998cited by this paper
• Biological roles of fibroblast growth factor-2.

  1997cited by this paper
• Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.

  1997cited by this paper
• Urokinase and Tissue-type Plasminogen Activator Are Required for the Mitogenic and Chemotactic Effects of Bovine Fibroblast Growth Factor and Platelet-derived Growth Factor-BB for Vascular Smooth Muscle Cells*

  1997cited by this paper
• Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma

  1997cited by this paper
• Epidemiology and risk factors in pancreatic cancer

  1996cited by this paper
• Cells retrovirally transfected with fibroblast growth factor-2 isoforms exhibit altered adenylate cyclase activity and G-protein functionality.

  1996cited by this paper
• Cytokine-induced selective increase of high-molecular-weight bFGF isoforms and their subcellular kinetics in cultured rat hippocampal astrocytes

  1996cited by this paper
• Plasminogen activators and matrix metalloproteinases in angiogenesis.

  1996influential reference
• Epidemiology and risk factors in pancreatic cancer.

  1996cited by this paper
• Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism.

  1996cited by this paper
• Epidemiology of and risk factors for pancreatic cancer.

  1995cited by this paper
• Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms

  1995cited by this paper
• Morphological and biological modifications induced in a rat pancreatic acinar cancer cell line (AR4-2J) by unscheduled expression of basic fibroblast growth factors.

  1993cited by this paper
• Caerulein and gastrin(2-17 ds) regulate differently synthesis of secretory enzymes, mRNA levels and cell proliferation in pancreatic acinar cells (AR4-2J).

  1993cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992influential reference
• Endocytosis and lysosomal delivery of tissue plasminogen activator-inhibitor 1 complexes in Hep G2 cells.

  1992cited by this paper
• Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor

  1991cited by this paper
• High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons.

  1989cited by this paper

• Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer

  2021cites this paper
• Deciphering role of FGFR signalling pathway in pancreatic cancer

  2019cites this paper
• THE ROLE OF EXTRACELLULAR VESICLES IN BREAST CANCER PROGRESSION AND DIAGNOSIS

  2016cites this paper
• Molecular Therapeutics: Pancreatic Cancer

  2015cites this paper
• Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.

  2015cites this paper
• Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models

  2013cites this paper
• FGF2 (fibroblast growth factor 2 (basic))

  2011cites this paper
• Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I.

  2005cites this paper
• Identification of c‐Jun as a critical mediator for the intracrine 24 kDa FGF‐2 isoform‐induced cell proliferation

  2005cites this paper
• Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro

  2004cites this paper
• Regulation and interactions in the activation of cell-associated plasminogen

  2004cites this paper
• Expression and localization of fibroblast growth factor (FGF) family members during the final growth of bovine ovarian follicles

  2004cites this paper
• Papel del activador tisular del plasminógeno (tPA) en el desarrollo y progresión tumoral pancreática en modelos murinos

  2004cites this paper
• Differential Intranuclear Localization of Fibroblast Growth Factor-2 Isoforms and Specific Interaction with the Survival of Motoneuron Protein*

  2003cites this paper
• Regulation of Plasminogen Activation HELI

  2003cites this paper
• Inhibitory Role of the Somatostatin Receptor SST2 on the Intracrine-regulated Cell Proliferation Induced by the 210-Amino Acid Fibroblast Growth Factor-2 Isoform

  2003cites this paper
• Age-related Changes in the Biomolecular Mechanisms of Clvarial Osteoblast Biology Affect Fibroblast Growth Factor-2 Signaling and Osteogenesis*

  2003cites this paper
• Regulation of plasminogen activation

  2003cites this paper
• Expression of the High Molecular Weight Fibroblast Growth Factor-2 Isoform of 210 Amino Acids Is Associated with Modulation of Protein Kinases C δ and ε and ERK Activation*

  2001cites this paper
• Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells

  2001cites this paper
• Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation.

  2001cites this paper
• Distinctive Effects of Rat Fibroblast Growth Factor-2 Isoforms on PC12 and Schwann Cells

  2001cites this paper
• Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles.

  2000cites this paper